Fondation Innovative Medicines for Tuberculosis (Im4tb)

Where the EU money came from

Funding by EU programme. Amounts are Fondation Innovative Medicines for Tuberculosis (Im4tb)'s own share of each project, not the project's full budget.

Projects

2 EU-funded projects, newest first. Each links to the official record.

• ERA4TBPartner

  EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS

  Horizon 2020 · 2020–2026 · Project on CORDIS ↗

  €15.2Mtheir share
• MM4TBPartner

  More Medicines for Tuberculosis

  FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗

  €455ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Ecole Polytechnique Federale de LausanneSwitzerland · 2 shared projects
• Uppsala UniversitetSweden · 2 shared projects
• Universita Degli Studi di PadovaItaly · 2 shared projects
• Institut PasteurFrance · 2 shared projects
• Universidad de ZaragozaSpain · 2 shared projects
• Universita Degli Studi di PaviaItaly · 2 shared projects
• Commissariat A L Energie Atomique et aux Energies AlternativesFrance · 1 shared project
• The Chancellor Masters and Scholars of the University of CambridgeUnited Kingdom · 1 shared project
• Eidgenoessische Technische Hochschule ZuerichSwitzerland · 1 shared project
• Institut National de la Sante et de la Recherche MedicaleFrance · 1 shared project
• Consiglio Nazionale Delle RicercheItaly · 1 shared project
• Lunds UniversitetSweden · 1 shared project
• Queen Mary University of LondonUnited Kingdom · 1 shared project
• Universidad Carlos Iii de MadridSpain · 1 shared project
• Universidad del Pais Vasco/ Euskal Herriko UnibertsitateaSpain · 1 shared project
• University of DundeeUnited Kingdom · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• artificial intelligence
• diabetes
• drug discovery
• genomes
• medicinal chemistry
• microfluidics
• primatology
• proteomics
• tuberculosis